1. Home
  2. MLYS vs HFWA Comparison

MLYS vs HFWA Comparison

Compare MLYS & HFWA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLYS
  • HFWA
  • Stock Information
  • Founded
  • MLYS 2019
  • HFWA 1927
  • Country
  • MLYS United States
  • HFWA United States
  • Employees
  • MLYS N/A
  • HFWA N/A
  • Industry
  • MLYS Biotechnology: Pharmaceutical Preparations
  • HFWA Banks
  • Sector
  • MLYS Health Care
  • HFWA Finance
  • Exchange
  • MLYS Nasdaq
  • HFWA Nasdaq
  • Market Cap
  • MLYS 1.0B
  • HFWA 843.8M
  • IPO Year
  • MLYS 2023
  • HFWA N/A
  • Fundamental
  • Price
  • MLYS $15.58
  • HFWA $23.38
  • Analyst Decision
  • MLYS Strong Buy
  • HFWA Hold
  • Analyst Count
  • MLYS 3
  • HFWA 3
  • Target Price
  • MLYS $33.00
  • HFWA $27.67
  • AVG Volume (30 Days)
  • MLYS 866.7K
  • HFWA 192.1K
  • Earning Date
  • MLYS 05-12-2025
  • HFWA 07-24-2025
  • Dividend Yield
  • MLYS N/A
  • HFWA 4.10%
  • EPS Growth
  • MLYS N/A
  • HFWA 11.50
  • EPS
  • MLYS N/A
  • HFWA 1.48
  • Revenue
  • MLYS N/A
  • HFWA $220,859,000.00
  • Revenue This Year
  • MLYS N/A
  • HFWA $23.49
  • Revenue Next Year
  • MLYS N/A
  • HFWA $7.68
  • P/E Ratio
  • MLYS N/A
  • HFWA $15.78
  • Revenue Growth
  • MLYS N/A
  • HFWA 0.16
  • 52 Week Low
  • MLYS $8.24
  • HFWA $16.55
  • 52 Week High
  • MLYS $18.38
  • HFWA $27.58
  • Technical
  • Relative Strength Index (RSI)
  • MLYS 54.41
  • HFWA 50.13
  • Support Level
  • MLYS $15.45
  • HFWA $23.11
  • Resistance Level
  • MLYS $16.11
  • HFWA $23.69
  • Average True Range (ATR)
  • MLYS 0.96
  • HFWA 0.55
  • MACD
  • MLYS -0.05
  • HFWA -0.07
  • Stochastic Oscillator
  • MLYS 51.56
  • HFWA 36.47

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

About HFWA Heritage Financial Corporation

Heritage Financial Corp is a bank holding company. The company through its subsidiary provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as noninterest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.

Share on Social Networks: